Colin ShannonPresident and
Chief Executive Officer
Since our inception in 1976, PRA has amassed a level of expertise that has enabled us to conduct complex global clinical trials across all therapeutic areas and provide outsourced clinical services across all phases of pharmaceutical and biotech drug development.
Our teams of experts are the core of the company promoting our forward-thinking culture with innovation, continuous attention to detail, constant quality improvement and a high priority approach to safety and timelines. Our pioneering mindset and specialist knowledge can make an enormous difference to your study.
Samir Shah serves as PRA Health Sciences’ Chief Operating Officer of the Strategic Solutions division. Offering years of significant industry experience, he is responsible for this division’s global operations, strategy and business functions. Mr. Shah joined the legacy RPS organization at its inception in 2000 before it was acquired by PRA in 2013. He was one of the key pioneers in the development and maturation of the Embedded sourcing model, creating market differentiation in the biopharmaceutical life science space. Mr. Shah’s expertise includes strategic sourcing, change management and optimizing effective governance and operating structures.
Prior to joining our team, Mr. Shah held various positions across clinical operations and business enablement in the biopharmaceutical industry at US Bioscience and Zeneca Pharmaceuticals and in the CRO sector at Theorom Clinical Research (formerly Biopharm/IBAH Clinical Services) and Parexel. In addition, Mr. Shah has served as a research scientist at the University of Pennsylvania Medical Center in the Department of Psychiatry. He has a BS degree from Saint Joseph’s University in Philadelphia.